REG - Inspiration Health - Trading Update

Inspiration HealthcareAnnouncement

16/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230216:nRSP0779Qa&default-theme=true

RNS Number : 0779Q  Inspiration Healthcare Group PLC  16 February 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Trading Update

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, is pleased to announce that, following the close of the financial
year ended 31 January 2023, the Group is expecting to report revenues of
approximately £41.2 million representing an increase of 0.4% compared to the
prior financial year and in line with market expectations. Adjusted
EBITDA(*) is also expected to be in line with market expectations.

The Company will be announcing its results for the financial year ended 31
January 2023 on Wednesday 3 May 2023.

Neil Campbell, Chief Executive Officer, commented:

"I am pleased to report that in recent months we have seen increased order
inflow and enjoyed a high level of interest in our products which has enabled
us to deliver a strong fourth quarter and gives a platform to achieve further
growth during FY24.

As has previously been reported, the unprecedented disruptions during last
year due to events outside of our control effectively stalled our growth.  It
is pleasing to see that despite this, and albeit modestly, compared to the
previous year our revenues have increased showing our resilience and also the
effectiveness of our business strategy.

Looking forward, we believe we are well placed to return to growth, and we
remain confident in the year ahead."

 

* Earnings before interest, tax, depreciation, amortisation, share based
payments and non-recurring items.

The information contained within this announcement is deemed to constitute
inside information as stipulated under the UK version of the EU Market Abuse
Regulation (2014/596) which is part of UK law by virtue of the European Union
(Withdrawal) Act 2018, as amended and supplemented from time to time. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.

Enquiries:

 Inspiration Healthcare Group plc                                                                                                                                                       Tel: 0330 175 0000

 Neil Campbell, Chief Executive Officer

 Nominated Adviser & Broker                                                                                                                                                             Tel: 0207 397 8900

 Cenkos Securities plc

 Stephen Keys

 Katy Birkin

 Dan Hodkinson

 Cadogan                                                                                                                                                                                Tel: 07771 713608
 PR

 Alex Walters

 alex.walters@cadoganpr.com (mailto:alex.walters@cadoganpr.com)

 

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in neonatal intensive care & operating theatres. The Company
provides high quality innovative products to patients around the world which
help to improve patient outcomes and it actively invests in innovative
product opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days
of life to help premature and sick babies; helping resuscitation and
stabilisation in the first moments of life through to preventing brain damage
and both invasive and non-invasive respiratory support in terms of capital
equipment and disposable medical devices. Additionally, the Company has its
own range of products for maintaining normothermia pre, during and
post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer,
manufacturer and supplier of single use respiratory products and sterile
medical consumables and S.L.E., a leading designer, manufacturer and global
provider of neonatal ventilation products.  The Group generates approximately
58% of its revenues from export markets and more than half of its revenues
come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a
distribution network, Inspiration Healthcare's success has been built on
continuous innovation, excellent customer service and an inherent commitment
to improving patient outcomes, working in close collaboration with key opinion
leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded
and complementary products from third parties, with an additional range of
home healthcare products.  This is supported by Technical Support for planned
preventative maintenance and emergency assistance.

 

The Group operates from various sites in the UK for R&D, Marketing and
operations with manufacturing based in Croydon (south London) and Hailsham
(East Sussex).  The Group's Head Office is located in Crawley, a short
distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.plc.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTSFSEDIEDSEFE